Heparin-induced thrombocytopenia: clinical manifestations and management strategies.
about
A novel allosteric pathway of thrombin inhibition: Exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acidsCurrent concepts review: venous thromboembolic disease in foot and ankle surgery.Acute adrenal insufficiency associated with heparin-induced thrombocytopenia.Current concepts review: heparin-induced thrombocytopenia.Clinical relevance of heparin-PF4 complex antibody in DVT after total joint replacementHeparin-induced thrombocytopenia and extracorporeal membrane oxygenation: a case report and review of the literatureThe Pharmacotherapy of Heparin-Induced Thrombocytopenia (HIT) : A Review of Contemporary Therapeutic Challenges in Clinical Practice.The incidence, causes, and prognostic significance of new-onset thrombocytopenia in intensive care units: a prospective cohort study in a Korean hospital.Efficacy and safety of off-label use of fondaparinux in the management of heparin-induced thrombocytopenia with thrombosis in an elderly woman.Restoration of adrenal function after bilateral adrenal damage due to heparin-induced thrombocytopenia (HIT): a case reportCharacterization of the plasma and blood anticoagulant potential of structurally and mechanistically novel oligomers of 4-hydroxycinnamic acidsAdvances in haematological pharmacotherapy in 21st century.Anticoagulation, delivered dose and outcomes in CRRT: The program to improve care in acute renal disease (PICARD).Discrepant post filter ionized calcium concentrations by common blood gas analyzers in CRRT using regional citrate anticoagulationIs there an alternative to systemic anticoagulation, as related to interventional biomedical devices?Basic science review: nitric oxide--releasing prosthetic materials.Case files of the Medical Toxicology Fellowship at Banner Good Samaritan Medical Center in Phoenix, AZ: a non-warfarin anticoagulant overdose.Assessment of the effects of different concentrations of ethylenediaminetetraacetic acid (EDTA) on erythrocytic indices of Nigerian White Fulani cattle and West African Dwarf goat.Cutaneous Drug Reactions in the Elderly.
P2860
Q24652951-AB8EE950-7882-4B5A-BC84-87337DB243CAQ33377443-5951F31B-193B-4C84-B17C-807A920CDFC6Q33380067-4156C765-CE81-4B2F-98C8-85372D26DFA7Q33382108-D7F43FDA-D20E-43BC-86BD-7EE2029B4896Q33384243-2255091F-6957-4E3B-9836-1871FF1E0222Q33394695-FB58C0CD-EC48-4EB1-B7C4-FBE025905ED5Q33401236-46C5306B-767C-47B0-A651-27368B8F744AQ33404467-6B9AE6BB-FE3C-4C80-AB38-3A0639800B5DQ33408949-85438294-4F2C-4053-B79C-992CE766EE82Q33420145-7E167B6F-628B-492B-9850-DF7F62063BC5Q33899404-A975E803-31F8-41C9-B46C-BFCA170DAF7CQ34406838-DAB0EC6C-AD0B-4215-B2E6-C2967708F52AQ34451757-29491EA0-CEB6-482D-9A51-B80CC08CB9EFQ36041145-98A34C6E-4105-4272-98FD-C66622182216Q36412659-F4A69148-2298-46EC-8182-AFF5BA63E3D7Q37272333-1CBBFBA2-4D28-4955-A787-FE787B00C355Q37624544-AD9C3718-AF06-410C-978B-42E964F13775Q46270849-2E48C7C1-5B1B-47AB-8DB5-C970B44A3CB2Q51803601-8E9CBCF6-7CAC-4F55-83F6-34C2303CA672
P2860
Heparin-induced thrombocytopenia: clinical manifestations and management strategies.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Heparin-induced thrombocytopenia: clinical manifestations and management strategies.
@ast
Heparin-induced thrombocytopenia: clinical manifestations and management strategies.
@en
type
label
Heparin-induced thrombocytopenia: clinical manifestations and management strategies.
@ast
Heparin-induced thrombocytopenia: clinical manifestations and management strategies.
@en
prefLabel
Heparin-induced thrombocytopenia: clinical manifestations and management strategies.
@ast
Heparin-induced thrombocytopenia: clinical manifestations and management strategies.
@en
P1476
Heparin-induced thrombocytopenia: clinical manifestations and management strategies.
@en
P2093
L Bernardo Menajovsky
P304
P356
10.1016/J.AMJMED.2005.06.005
P407
P478
118 Suppl 8A
P577
2005-08-01T00:00:00Z